Year |
Citation |
Score |
2016 |
Hudry E, Martin C, Gandhi S, György B, Scheffer DI, Mu D, Merkel SF, Mingozzi F, Fitzpatrick Z, Dimant H, Masek M, Ragan T, Tan S, Brisson AR, Ramirez SH, et al. Exosome-associated AAV vector as a robust and convenient neuroscience tool. Gene Therapy. PMID 26836117 DOI: 10.1038/Gt.2016.11 |
0.436 |
|
2014 |
Dimant H, Zhu L, Kibuuka LN, Fan Z, Hyman BT, McLean PJ. Direct visualization of CHIP-mediated degradation of alpha-synuclein in vivo: implications for PD therapeutics. Plos One. 9: e92098. PMID 24664141 DOI: 10.1371/Journal.Pone.0092098 |
0.703 |
|
2014 |
McFarland NR, Dimant H, Kibuuka L, Ebrahimi-Fakhari D, Desjardins CA, Danzer KM, Danzer M, Fan Z, Schwarzschild MA, Hirst W, McLean PJ. Chronic treatment with novel small molecule Hsp90 inhibitors rescues striatal dopamine levels but not α-synuclein-induced neuronal cell loss. Plos One. 9: e86048. PMID 24465863 DOI: 10.1371/Journal.Pone.0086048 |
0.581 |
|
2013 |
Dimant H, Kalia SK, Kalia LV, Zhu LN, Kibuuka L, Ebrahimi-Fakhari D, McFarland NR, Fan Z, Hyman BT, McLean PJ. Direct detection of alpha synuclein oligomers in vivo. Acta Neuropathologica Communications. 1: 6. PMID 24252244 DOI: 10.1186/2051-5960-1-6 |
0.574 |
|
2012 |
Dimant H, Ebrahimi-Fakhari D, McLean PJ. Molecular chaperones and co-chaperones in Parkinson disease. The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry. 18: 589-601. PMID 22829394 DOI: 10.1177/1073858412441372 |
0.632 |
|
2010 |
Dimant H, Solomon B. Filamentous phages reduce alpha-synuclein oligomerization in the membrane fraction of SH-SY5Y cells. Neuro-Degenerative Diseases. 7: 203-5. PMID 20224286 DOI: 10.1159/000295664 |
0.536 |
|
2009 |
Dimant H, Sharon N, Solomon B. Modulation effect of filamentous phage on alpha-synuclein aggregation. Biochemical and Biophysical Research Communications. 383: 491-6. PMID 19379715 DOI: 10.1016/J.Bbrc.2009.04.048 |
0.491 |
|
2009 |
Dimant H, Sharon N, Solomon B. P3.004 Modulation of alpha synuclein aggregation by fllamentous phages Parkinsonism & Related Disorders. 15: S148. DOI: 10.1016/S1353-8020(09)70568-1 |
0.485 |
|
Low-probability matches (unlikely to be authored by this person) |
2010 |
Orgad S, Dimant H, Dor-On E, Azriel-Rosenfeld R, Benhar I, Solomon B. TAR1, a human anti-p53 single-chain antibody, restores tumor suppressor function to mutant p53 variants. Journal of Immunotherapy (Hagerstown, Md. : 1997). 33: 146-54. PMID 20139776 DOI: 10.1097/Cji.0B013E3181Be14Dc |
0.263 |
|
2019 |
Mazur C, Powers B, Zasadny K, Sullivan JM, Dimant H, Kamme F, Hesterman J, Matson J, Oestergaard M, Seaman M, Holt RW, Qutaish M, Polyak I, Coelho R, Gottumukkala V, et al. Brain pharmacology of intrathecal antisense oligonucleotides revealed through multimodal imaging. Jci Insight. 4. PMID 31619586 DOI: 10.1172/Jci.Insight.129240 |
0.25 |
|
2023 |
Yost SA, Firlar E, Glenn JD, Carroll HB, Foltz S, Giles AR, Egley JM, Firnberg E, Cho S, Nguyen T, Henry WM, Janczura KJ, Bruder J, Liu Y, Danos O, ... ... Dimant H, et al. Characterization and biodistribution of under-employed gene therapy vector AAV7. Journal of Virology. e0116323. PMID 37843374 DOI: 10.1128/jvi.01163-23 |
0.199 |
|
2004 |
Dahan A, Dimant H, Portnoy M. Synthesis of tetrafurcated dendritic units on solid support. Journal of Combinatorial Chemistry. 6: 305-7. PMID 15132588 DOI: 10.1021/Cc0340630 |
0.198 |
|
Hide low-probability matches. |